Browse our anti-CD137 (TNFRSF9) Antibodies

Full name:
anti-Tumor Necrosis Factor Receptor Superfamily, Member 9 Antibodies (TNFRSF9)
On are 326 Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9) Antibodies from 24 different suppliers available. Additionally we are shipping CD137 Proteins (62) and CD137 Kits (28) and many more products for this protein. A total of 426 CD137 products are currently listed.
4-1BB, A930040I11Rik, AA408498, AI325004, Cd137, CDw137, ILA, Ly63, TNFRSF9, zgc:136557
list all antibodies Gene Name GeneID UniProt
TNFRSF9 3604 Q07011
TNFRSF9 21942 P20334

Show all species

Show all synonyms

Most Popular Reactivities for anti-CD137 (TNFRSF9) Antibodies

Select your species and application

anti-Human CD137 Antibodies:

anti-Mouse (Murine) CD137 Antibodies:

anti-Rat (Rattus) CD137 Antibodies:

All available anti-CD137 Antibodies

Go to our pre-filtered search.

Top referenced anti-CD137 Antibodies

  1. Human Monoclonal CD137 Primary Antibody for FACS, IF - ABIN2663017 : Alderson, Smith, Tough, Davis-Smith, Armitage, Falk, Roux, Baker, Sutherland, Din: Molecular and biological characterization of human 4-1BB and its ligand. in European journal of immunology 1994 (PubMed)
    Show all 8 references for 2663017

  2. Human Monoclonal CD137 Primary Antibody for FACS - ABIN2665542 : Schwarz, Blanco, von Kempis, Valbracht, Lotz: ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. in Blood 1996 (PubMed)
    Show all 8 references for 2665542

  3. Human Monoclonal CD137 Primary Antibody for FACS - ABIN2657240 : Gruss, Dower: Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. in Blood 1995 (PubMed)
    Show all 8 references for 2657240

  4. Human Monoclonal CD137 Primary Antibody for FACS - ABIN2660941 : Sica, Chen: Modulation of the immune response through 4-1BB. in Advances in experimental medicine and biology 2000 (PubMed)
    Show all 8 references for 2660941

  5. Human Monoclonal CD137 Primary Antibody for Func, FACS - ABIN610408 : Boulton, Cobb: Identification of multiple extracellular signal-regulated kinases (ERKs) with antipeptide antibodies. in Cell regulation 1991 (PubMed)
    Show all 4 references for 610408

  6. Human Polyclonal CD137 Primary Antibody for IF (p), IHC (p) - ABIN740445 : Daquinag, Tseng, Salameh, Zhang, Amaya-Manzanares, Dadbin, Florez, Xu, Tong, Kolonin: Depletion of white adipocyte progenitors induces beige adipocyte differentiation and suppresses obesity development. in Cell death and differentiation 2014 (PubMed)
    Show all 2 references for 740445

  7. Human Polyclonal CD137 Primary Antibody for ELISA (Detection), FACS - ABIN4899793 : Lindstedt, Johansson-Lindbom, Borrebaeck: Expression of CD137 (4-1BB) on human follicular dendritic cells. in Scandinavian journal of immunology 2003 (PubMed)

  8. Human Polyclonal CD137 Primary Antibody for ELISA, WB - ABIN1533841 : Schwarz, Tuckwell, Lotz: A receptor induced by lymphocyte activation (ILA): a new member of the human nerve-growth-factor/tumor-necrosis-factor receptor family. in Gene 1994 (PubMed)

More Antibodies against CD137 Interaction Partners

Human Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9) interaction partners

  1. Egr2 (show EGR2 Antibodies)-driven cell surface proteins LAG-3 (show LAG3 Antibodies) and 4-1BB can identify dysfunctional tumor antigen-specific CD8 (show CD8A Antibodies)(+) TIL (show TLR1 Antibodies).

  2. Findings indicate that CD137 antigen is a useful marker that can be used for identifying Mycobacterium tuberculosis (Mtb (show NCAPG2 Antibodies))-reactive CD4 (show CD4 Antibodies)(+) T cells (Mtb (show NCAPG2 Antibodies)-reactive CD4 (show CD4 Antibodies)(+) T cells) by flow cytometry.

  3. Anti-4-1BB single chain variable fragments enhanced surface CD69 (show CD69 Antibodies) expression and interleukin-2 (show IL2 Antibodies) production in stimulated CCRF-CEM cells which confirmed the agonistic effect of the selected single chain variable fragments. The data from this study have provided a rationale for further experiments involving the biological functions of anti-4-1BB single chain variable fragments in future studies.

  4. Studies suggest that adoptive T cell therapy and CD137 antigen offer much opportunity to raise the efficacy of current cancer immunotherapies.

  5. Triple costimulation via CD80 (show CD80 Antibodies), 4-1BB, and CD83 (show CD83 Antibodies) ligand elicits the long-term growth of Vgamma9Vdelta2 T cells in low levels of IL-2 (show IL2 Antibodies).

  6. These studies provide the first direct evidence that ligation of tumour necrosis factor (show TNF Antibodies) superfamily members and their cognate receptors is important for the control of viral lytic replication.

  7. Our findings provide a novel, TNFRSF9-positive, reactive astrocytic phenotype in human gliomas

  8. Human genetic evidence for involvement of CD137 in atherosclerosis

  9. As a result of becoming activated, transferred human T lymphocytes express the inducible surface antigens hPD-1 (show PDCD1 Antibodies) and hCD137 on their plasma membrane.

  10. Our results provide biological explanations for the antitumor effects of CD19 (show CD19 Antibodies) CARs and for the observations that CD19 (show CD19 Antibodies) CAR T cells incorporating the 4-1BB costimulatory domain are more persistent than those incorporating CD28 (show CD28 Antibodies) in clinical trials.

Mouse (Murine) Tumor Necrosis Factor Receptor Superfamily, Member 9 (TNFRSF9) interaction partners

  1. results indicate that one important diabetogenic function of CD137 is to promote the expansion and accumulation of beta cell-autoreactive CD8 (show CD8A Antibodies) T cells, and in the absence of CD137 or its interaction with CD137 ligand, type 1 diabetes progression is suppressed

  2. High CD137 expression is associated with neoplasms.

  3. Ly6C, 4-1BB, and KLRG1 (show KLRG1 Antibodies) have roles in the activation of lamina propria lymphocytes in the small intestine in a mouse model of Crohn's disease

  4. CD137 Regulates NFATc1 (show NFATC1 Antibodies) Expression in Mouse VSMCs through TRAF6 (show TRAF6 Antibodies)/NF-kappaB (show NFKB1 Antibodies) p65 (show NFkBP65 Antibodies) Signaling Pathway.

  5. 4-1BB triggering preferentially enhances the expansion of CD8 (show CD8A Antibodies)+ T cells through the amplification of autocrine IL-2 (show IL2 Antibodies)/IL-2R signaling loop.

  6. c-IAP (show ALPI Antibodies) ubiquitin protein ligase (show UBE2K Antibodies) activity is required for 4-1BB signaling and CD8 (show CD8A Antibodies)(+) memory T-cell survival.

  7. we conclude that in vivo 4-1BB signaling of myeloid cells negatively regulates peripheral T cell responses

  8. activation of CD137 signaling decreases the stability of advanced atherosclerotic plaques via its combined effects on Teff cells, vascular smooth muscle cells, and macrophages

  9. 4-1BB mediates the inflammatory responses in obese skeletal muscle by interacting with its ligand 4-1BBL (show TNFSF9 Antibodies) on macrophages.

  10. CD137-CD137L (show TNFSF9 Antibodies) interactions mediated via regulation of CyPA (show PPIA Antibodies) contribute to the progression of atherosclerosis.

CD137 (TNFRSF9) Antigen Profile

Antigen Summary

The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor contributes to the clonal expansion, survival, and development of T cells. It can also induce proliferation in peripheral monocytes, enhance T cell apoptosis induced by TCR/CD3 triggered activation, and regulate CD28 co-stimulation to promote Th1 cell responses. The expression of this receptor is induced by lymphocyte activation. TRAF adaptor proteins have been shown to bind to this receptor and transduce the signals leading to activation of NF-kappaB.

Alternative names and synonyms associated with CD137 (TNFRSF9)

  • tumor necrosis factor receptor superfamily, member 9 (TNFRSF9) antibody
  • tumor necrosis factor receptor superfamily, member 9a (tnfrsf9a) antibody
  • tumor necrosis factor receptor superfamily, member 9 (LOC100348914) antibody
  • tumor necrosis factor receptor superfamily, member 9 (Tnfrsf9) antibody
  • 4-1BB antibody
  • A930040I11Rik antibody
  • AA408498 antibody
  • AI325004 antibody
  • Cd137 antibody
  • CDw137 antibody
  • ILA antibody
  • Ly63 antibody
  • TNFRSF9 antibody
  • zgc:136557 antibody

Protein level used designations for TNFRSF9

tumor necrosis factor receptor superfamily, member 9 , tumor necrosis factor receptor superfamily member 9 , 4-1BB ligand receptor , CD137 antigen , T cell antigen ILA , T-cell antigen 4-1BB homolog , T-cell antigen ILA , homolog of mouse 4-1BB , induced by lymphocyte activation (ILA) , interleukin-activated receptor, homolog of mouse Ly63 , receptor protein 4-1BB , T-cell antigen 4-1BB , secreted CD137 antigen

419365 Gallus gallus
520341 Bos taurus
608274 Canis lupus familiaris
678622 Danio rerio
708281 Macaca mulatta
746029 Pan troglodytes
100196937 Papio anubis
100348914 Oryctolagus cuniculus
3604 Homo sapiens
21942 Mus musculus
Selected quality suppliers for anti-CD137 (TNFRSF9) Antibodies
Did you look for something else?